Finance

Lists
NMRA:NASDAQ
Neumora Therapeutics Inc
0,48 US$
-0,85%
(-0,0041) 1D
0,48 US$
+0,90% (+0,0043)
After hours
Closed: 9 ოქტ, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NMRA...
Open
0,47 US$
High
0,51 US$
Low
0,47 US$
Mkt. cap
89,34 მლნ.
Avg. vol.
1,73 მლნ.
Volume
789,43 ათ.
52-wk high
3,65 US$
52-wk low
0,45 US$
EPS
-1,23 US$
Beta
2,95
Shares outstanding
187,90 მლნ.
No. of employees
63
Open
0,47 US$
High
0,51 US$
Low
0,47 US$
Mkt. cap
89,34 მლნ.
Avg. vol.
1,73 მლნ.
Volume
789,43 ათ.
52-wk high
3,65 US$
52-wk low
0,45 US$
EPS
-1,23 US$
Beta
2,95
Shares outstanding
187,90 მლნ.
No. of employees
63
News stories
From web sources and news partners
About Neumora Therapeutics Inc
CEO-
Employees63
Founded2019
HeadquartersWatertown, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
SectorPharmaceutical industry
Analyst ratings
Based on 5 analysts giving stock ratings to NMRA in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for NMRA in the last 3 months.
Highest
Current 0,48 US$
7,00 US$ (+1 371,52%)
Average
5,25 US$ (+1 003,64%)
Lowest
4,00 US$ (+740,87%)
Analyst
Recommendation
Action
Price target
Projected
Date
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
7,00 US$
+1 371,5%
08/24/2026
Graig Suvannavejh
Mizuho Securities
Buy
Reiterated
4,00 US$
+740,9%
08/17/2026
Ami Fadia
Needham
Buy
Reiterated
5,00 US$
+951,1%
08/14/2026
Myles Minter
William Blair
Buy
Reiterated
-
-
08/14/2026
Brian Abrahams
RBC Capital
Buy
Maintained
5,00 US$
+951,1%
08/14/2026
Tessa Romero
J.P. Morgan
Sell
Maintained
-
-
05/26/2026
Paul Matteis
Stifel Nicolaus
Hold
Maintained
3,00 US$
+530,6%
05/12/2026
Yatin Suneja
Guggenheim
Buy
Maintained
14,00 US$
+2 843%
05/07/2026
Last report
14 აგვ. 2026
Fiscal period
Q2 2026
-0,23 US$ / -0,24 US$
+5,34%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
40,52 მლნ.
44,67 მლნ.
38,60 მლნ.
29,28 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12,18 მლნ.
13,81 მლნ.
14,27 მლნ.
12,91 მლნ.
Operating expense
52,70 მლნ.
58,48 მლნ.
52,86 მლნ.
42,19 მლნ.
Total operating expenses
52,70 მლნ.
58,48 მლნ.
52,86 მლნ.
42,19 მლნ.
Operating income
-52,70 მლნ.
-58,48 მლნ.
-52,86 მლნ.
-42,19 მლნ.
Other non operating income
7,00 ათ.
-269,00 ათ.
59,00 ათ.
-7,00 ათ.
EBT including unusual items
-56,76 მლნ.
-59,45 მლნ.
-53,43 მლნ.
-43,08 მლნ.
EBT excluding unusual items
-51,76 მლნ.
-59,45 მლნ.
-53,43 მლნ.
-43,08 მლნ.
Income tax expense
-
-
30,00 ათ.
-
Effective tax rate
-
-
-0,06%
-
Other operating expenses
-
-
-
-
Net income
-56,76 მლნ.
-59,45 მლნ.
-53,46 მლნ.
-43,08 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,35
-0,35
-0,30
-0,23
Interest and investment income
1,68 მლნ.
1,34 მლნ.
1,23 მლნ.
935,00 ათ.
Interest expense
-747,00 ათ.
-2,04 მლნ.
-1,85 მლნ.
-1,82 მლნ.
Net interest expenses
938,00 ათ.
-701,00 ათ.
-623,00 ათ.
-885,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-52,68 მლნ.
-58,47 მლნ.
-52,86 მლნ.
-42,18 მლნ.
Gain or loss from assets sale
-62,00 ათ.
264,00 ათ.
-71,00 ათ.
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები